Abiopharma

Clinical trial NCT02425904: completion date: 2026-07-30 → 2026-12-31.

Clinical trial NCT07656415: completion date: 2030-02-01 → 2030-08-01.

Clinical trial NCT04080804 updates: 1. completion date: 2026-10-17 → 2027-10-31 2. primary completion date: 2026-07-17 → 2027-10-01

Clinical trial NCT07257120 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2027-11-30 → 2026-06-08 3. primary completion date: 2027-11-30 → 2026-06-08 4. enrollment: 8 → 10 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06778122: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT07531745: start date: 2026-04-01 → 2026-05-21.

Clinical trial NCT06803043: collaborators removed: Rhode Island Hospital.

Clinical trial NCT06201728 updates: 1. status: ENROLLING_BY_INVITATION → ACTIVE_NOT_RECRUITING 2. completion date: 2026-09-01 → 2026-12-31 3. primary completion date: 2026-09-01 → 2026-06-18

Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s)::Becoming a Substantial Shareholder – Vitters Sim Yu Xiong

Clinical trial NCT03901963 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-29 → 2026-05-04